Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways.
Saved in:
| Title: | Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways. |
|---|---|
| Authors: | Kheraldine, Hadeel1,2 (AUTHOR), Gupta, Ishita1,3 (AUTHOR), Cyprian, Farhan Sachal1,2 (AUTHOR), Vranic, Semir1 (AUTHOR), Al-Farsi, Halema F.1 (AUTHOR), Merhi, Maysaloun4,5 (AUTHOR), Dermime, Said4,5 (AUTHOR), Al Moustafa, Ala-Eddin1,2,6 (AUTHOR) aalmoustafa@qu.edu.qa |
| Source: | Cancer Cell International. 3/2/2024, Vol. 24 Issue 1, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 175827323 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Kheraldine%2C+Hadeel%22">Kheraldine, Hadeel</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gupta%2C+Ishita%22">Gupta, Ishita</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cyprian%2C+Farhan+Sachal%22">Cyprian, Farhan Sachal</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vranic%2C+Semir%22">Vranic, Semir</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Al-Farsi%2C+Halema+F%2E%22">Al-Farsi, Halema F.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Merhi%2C+Maysaloun%22">Merhi, Maysaloun</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dermime%2C+Said%22">Dermime, Said</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Al+Moustafa%2C+Ala-Eddin%22">Al Moustafa, Ala-Eddin</searchLink><relatesTo>1,2,6</relatesTo> (AUTHOR)<i> aalmoustafa@qu.edu.qa</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+Cell+International%22">Cancer Cell International</searchLink>. 3/2/2024, Vol. 24 Issue 1, p1-15. 15p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=175827323 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12935-023-03195-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 15 StartPage: 1 Titles: – TitleFull: Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kheraldine, Hadeel – PersonEntity: Name: NameFull: Gupta, Ishita – PersonEntity: Name: NameFull: Cyprian, Farhan Sachal – PersonEntity: Name: NameFull: Vranic, Semir – PersonEntity: Name: NameFull: Al-Farsi, Halema F. – PersonEntity: Name: NameFull: Merhi, Maysaloun – PersonEntity: Name: NameFull: Dermime, Said – PersonEntity: Name: NameFull: Al Moustafa, Ala-Eddin IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 03 Text: 3/2/2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 14752867 Numbering: – Type: volume Value: 24 – Type: issue Value: 1 Titles: – TitleFull: Cancer Cell International Type: main |
| ResultId | 1 |
